These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The liposomal formulation of doxorubicin. Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375 [TBL] [Abstract][Full Text] [Related]
3. Liposomal drug delivery system from laboratory to clinic. Kshirsagar NA; Pandya SK; Kirodian GB; Sanath S J Postgrad Med; 2005; 51 Suppl 1():S5-15. PubMed ID: 16519249 [TBL] [Abstract][Full Text] [Related]
4. Use of liposomes as injectable-drug delivery systems. Ostro MJ; Cullis PR Am J Hosp Pharm; 1989 Aug; 46(8):1576-87. PubMed ID: 2672806 [TBL] [Abstract][Full Text] [Related]
5. Liposome-based drug delivery systems. Langner M; Kral TE Pol J Pharmacol; 1999; 51(3):211-22. PubMed ID: 10600035 [TBL] [Abstract][Full Text] [Related]
6. Tailoring liposomes for cancer drug delivery: from the bench to the clinic. Gabizon A Ann Biol Clin (Paris); 1993; 51(9):811-3. PubMed ID: 8166395 [TBL] [Abstract][Full Text] [Related]
7. The potential of liposomal drug delivery for the treatment of inflammatory arthritis. Vanniasinghe AS; Bender V; Manolios N Semin Arthritis Rheum; 2009 Dec; 39(3):182-96. PubMed ID: 18926560 [TBL] [Abstract][Full Text] [Related]
8. Coformulated N-octanoyl-glucosylceramide improves cellular delivery and cytotoxicity of liposomal doxorubicin. Veldman RJ; Koning GA; van Hell A; Zerp S; Vink SR; Storm G; Verheij M; van Blitterswijk WJ J Pharmacol Exp Ther; 2005 Nov; 315(2):704-10. PubMed ID: 16040815 [TBL] [Abstract][Full Text] [Related]
9. Long-circulating sterically stabilized liposomes in the treatment of infections. Bakker-Woudenberg IA; Schiffelers RM; Storm G; Becker MJ; Guo L Methods Enzymol; 2005; 391():228-60. PubMed ID: 15721385 [TBL] [Abstract][Full Text] [Related]
10. Liposome-based drug delivery to alveolar macrophages. Vyas SP; Khatri K Expert Opin Drug Deliv; 2007 Mar; 4(2):95-9. PubMed ID: 17335407 [TBL] [Abstract][Full Text] [Related]
13. Liposomal cytokines in the treatment of infectious diseases and cancer. ten Hagen TL Methods Enzymol; 2005; 391():125-45. PubMed ID: 15721378 [TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Li X; Ding L; Xu Y; Wang Y; Ping Q Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296 [TBL] [Abstract][Full Text] [Related]
15. Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery. Fahr A; van Hoogevest P; May S; Bergstrand N; S Leigh ML Eur J Pharm Sci; 2005 Nov; 26(3-4):251-65. PubMed ID: 16112849 [TBL] [Abstract][Full Text] [Related]
16. Atomic force microscopy: a tool to study the structure, dynamics and stability of liposomal drug delivery systems. Spyratou E; Mourelatou EA; Makropoulou M; Demetzos C Expert Opin Drug Deliv; 2009 Mar; 6(3):305-17. PubMed ID: 19327046 [TBL] [Abstract][Full Text] [Related]
17. Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells. Lu Y; Wu J; Wu J; Gonit M; Yang X; Lee A; Xiang G; Li H; Liu S; Marcucci G; Ratnam M; Lee RJ Mol Pharm; 2007; 4(5):707-12. PubMed ID: 17708654 [TBL] [Abstract][Full Text] [Related]
18. Liposomes in ultrasonic drug and gene delivery. Huang SL Adv Drug Deliv Rev; 2008 Jun; 60(10):1167-76. PubMed ID: 18479776 [TBL] [Abstract][Full Text] [Related]
20. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial]. Rieger CT; Dittmer M; Ostermann H Dtsch Med Wochenschr; 2007 Oct; 132(40):2062-6. PubMed ID: 17899499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]